Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study was designed to investigate the clinical safety, tolerability and efficacy of
prucalopride in improving the symptoms associated with chronic intestinal pseudo-obstruction
(CIP) in subjects with CIP. The study hypothesis was that prucalopride at doses up to 4 mg is
safe, well tolerated, efficacious and improves the symptoms associated with CIP.